1

Not known Details About Journal of Leukemia Research

News Discuss 
Together with azacitidine or decitabine, or minimal-dose cytarabine in newly diagnosed AML aged ≥ seventy five decades or with co-morbidities that preclude the usage of intense induction chemotherapy Nevertheless, it’s important to Observe that this determine incorporates people today of all ages and with all kinds of leukemia. Rated in https://directivepublications.org/journal-of-leukemia-research/

Comments

    No HTML

    HTML is disabled


Who Upvoted this Story